Results for tag: "Zerbaxa"

Zerbaxa is a market of gastrointestinal drugs used to treat a variety of conditions, including bacterial infections, irritable bowel syndrome, and Crohn's disease. These drugs are typically administered orally or intravenously, and can be used to treat both acute and chronic conditions. Zerbaxa drugs are typically prescribed by a physician and are available in both generic and brand-name formulations. The Zerbaxa market is highly competitive, with a wide range of products available from a variety of manufacturers. Many of these manufacturers are large pharmaceutical companies, such as Pfizer, Merck, and GlaxoSmithKline, while others are smaller, specialized companies. Additionally, there are a number of generic drug manufacturers that produce generic versions of Zerbaxa drugs. Some of the companies in the Zerbaxa market include Pfizer, Merck, GlaxoSmithKline, Novartis, AstraZeneca, Sanofi, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more